Neurontin Snigdha Prakash reports on new documents showing that drug giant Parke Davis promoted the use of neurontin for pain treatment, even though it was not approved by the FDA for that use. Documents come from a trial underway in federal court in Boston.

Neurontin

Neurontin

  • Download
  • <iframe src="https://www.npr.org/player/embed/827166/827167" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Snigdha Prakash reports on new documents showing that drug giant Parke Davis promoted the use of neurontin for pain treatment, even though it was not approved by the FDA for that use. Documents come from a trial underway in federal court in Boston.